Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.
Puzanov I, Diab A, Abdallah K, Bingham CO 3rd, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D, Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL, Ernstoff MS; Society for Immunotherapy of Cancer Toxicity Management Working Group. Puzanov I, et al. Among authors: shannon v. J Immunother Cancer. 2017 Nov 21;5(1):95. doi: 10.1186/s40425-017-0300-z. J Immunother Cancer. 2017. PMID: 29162153 Free PMC article.
Immune-Related Adverse Events: Pneumonitis.
Jain A, Shannon VR, Sheshadri A. Jain A, et al. Adv Exp Med Biol. 2018;995:131-149. doi: 10.1007/978-3-030-02505-2_6. Adv Exp Med Biol. 2018. PMID: 30539509 Review.
Immune-Related Adverse Events: Pneumonitis.
Zhong L, Altan M, Shannon VR, Sheshadri A. Zhong L, et al. Adv Exp Med Biol. 2020;1244:255-269. doi: 10.1007/978-3-030-41008-7_13. Adv Exp Med Biol. 2020. PMID: 32301020 Free PMC article. Review.
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors.
Dougan M, Blidner AG, Choi J, Cooksley T, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Anderson R, Rapoport BL. Dougan M, et al. Support Care Cancer. 2020 Dec;28(12):6129-6143. doi: 10.1007/s00520-020-05707-3. Epub 2020 Aug 27. Support Care Cancer. 2020. PMID: 32856210 Free PMC article. Review.
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors.
Choi J, Anderson R, Blidner A, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL, Lacouture ME. Choi J, et al. Support Care Cancer. 2020 Dec;28(12):6119-6128. doi: 10.1007/s00520-020-05706-4. Epub 2020 Aug 27. Support Care Cancer. 2020. PMID: 32856211 Free PMC article. Review.
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors.
Suarez-Almazor ME, Pundole X, Abdel-Wahab N, Johnson DB, Gupta D, Glezerman I, Cooksley T, Anderson R, Blidner A, Choi J, Dougan M, Ginex P, Girotra M, Shannon VR, Rapoport BL. Suarez-Almazor ME, et al. Support Care Cancer. 2020 Dec;28(12):6159-6173. doi: 10.1007/s00520-020-05710-8. Epub 2020 Aug 27. Support Care Cancer. 2020. PMID: 32856212 Review.
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities.
Cooksley T, Girotra M, Ginex P, Gordon RA, Anderson R, Blidner A, Choi J, Dougan M, Glezerman I, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL. Cooksley T, et al. Support Care Cancer. 2020 Dec;28(12):6175-6181. doi: 10.1007/s00520-020-05709-1. Epub 2020 Aug 27. Support Care Cancer. 2020. PMID: 32856213 Review.
Cancer immunotherapy-related adverse events: causes and challenges.
Blidner AG, Choi J, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL, Anderson R. Blidner AG, et al. Support Care Cancer. 2020 Dec;28(12):6111-6117. doi: 10.1007/s00520-020-05705-5. Epub 2020 Aug 28. Support Care Cancer. 2020. PMID: 32857220 Review.
76 results